Edition:
United Kingdom

Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

8.75USD
23 May 2018
Change (% chg)

$-0.15 (-1.69%)
Prev Close
$8.90
Open
$8.85
Day's High
$8.85
Day's Low
$8.60
Volume
3,347
Avg. Vol
7,295
52-wk High
$9.20
52-wk Low
$5.70

Select another date:

Wed, May 9 2018

BRIEF-Chembio Diagnostics Reports Q1 Loss Per Share $0.05

* CHEMBIO DIAGNOSTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Chembio Diagnostics And Lumiradx Enter Collaboration To Develop New Point-Of-Care Diagnostic Tests For Infectious Diseases

* CHEMBIO DIAGNOSTICS AND LUMIRADX ENTER COLLABORATION TO DEVELOP NEW POINT-OF-CARE DIAGNOSTIC TESTS FOR INFECTIOUS DISEASES

BRIEF-Chembio Diagnostics Q4 Loss Per Share $0.16

* CHEMBIO DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Chembio Diagnostics Announces Proposed Public Offering Of Common Stock

* CHEMBIO DIAGNOSTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

BRIEF-Chembio Diagnostics Announces Major New Tender Win And Certain Preliminary 2017 Financial Results

* CHEMBIO DIAGNOSTICS ANNOUNCES MAJOR NEW TENDER WIN AND CERTAIN PRELIMINARY 2017 FINANCIAL RESULTS

BRIEF-Chembio Diagnostics Appoints Neil Goldman As CFO

* CHEMBIO DIAGNOSTICS ANNOUNCES APPOINTMENT OF NEIL A. GOLDMAN AS CHIEF FINANCIAL OFFICER

BRIEF-Chembio Diagnostics And Astrazeneca Collaborates To Develop Point-Of-Care Diagnostic Test

* CHEMBIO DIAGNOSTICS AND ASTRAZENECA ENTER A COLLABORATION TO DEVELOP POINT-OF-CARE DIAGNOSTIC TEST

BRIEF-Chembio receives $8.5 mln commitment from Bio-Manguinhos to purchase components for production of dpp Assays in Brazil during 2018

* CHEMBIO RECEIVES $8.5 MILLION COMMITMENT FROM BIO-MANGUINHOS TO PURCHASE COMPONENTS FOR PRODUCTION OF DPP® ASSAYS IN BRAZIL DURING 2018

BRIEF-Chembio Diagnostics Awarded UNICEF Contract

* CHEMBIO DIAGNOSTICS AWARDED UNICEF CONTRACT TO SUPPLY POINT-OF-CARE DPP® ZIKA ASSAYS AND DPP® MICRO READERS

Select another date: